
According to Benzinga Pro data, during Q1, Immunogen (NASDAQ:IMGN) posted sales of $38.08 million. Earnings were up 35.05%, but Immunogen still reported an overall loss of $24.14 million. In Q4, Immunogen brought in $27.99 million in sales but lost $37.17 million in earnings.